tirzepatide.vs semaglutide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? Semaglutide vs Tirzepatide vs Liraglutide

Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia

Potential Adverse Effects and Hazards Common side effects: Nausea and vomiting Diarrhea or constipation Stomach pain or bloating Reduced appetite Serious risks (rare): Pancreatitis Gallbladder disease Kidney problems Allergic reactions Cautions: Contraindicated in case of the following personal history: medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 Do not forget to discuss Semaglutide contraindications with your physician

Pharmacy to meet your full range of needs

1 The FLOW trial achieved its primary endpoint with Ozempic 1 mg, demonstrating a statistically significant and superior 24% relative risk reduction of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease (4.9% absolute risk reduction at 3 years) compared to placebo, when added to standard of care

KI: Writing review and editing

Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency